Better Therapeutics (NASDAQ: BTTX) is a prescription digital therapeutics company developing a novel form of cognitive behavioral therapy (CBT) to address the root causes of cardiometabolic diseases while lowering healthcare costs. The CBT designed to enable changes in the brain’s neural pathways in order to effect lasting changes in behavior. The company has developed a proprietary platform for developing FDA-regulated, software-based solutions for type 2 diabetes, heart disease, and other conditions . . .